Prior Speakers
Jim Allison
2018 Nobel Laureate
Dr. Robert Weinberg
Wolf Prize Awardee, Daniel K. Ludwig Professor for Cancer Research at Whitehead Institute
Dr. Ronald DePinho
President, MD Anderson Cancer Center
Isaac Blech
HNW Biotech Investor
Dr. Irving Weissman
Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine
Dennis Purcell
Founder of Aisling Capital
Phil Ross
Global Head of Healthcare Banking - JP Morgan
Raju Kuckerlapati
Founder Millennium and Professor Genetics, Harvard
Alfred Slanetz
Frm CEO Bluebird Bio, CEO Geneius Biotechnology
Greg Simon
President, Biden Cancer Initiative
David Schlotterbeck
Frm Vice Chairman Cardinal Health / CEO & Chair Carefusion
Dr. Brian Lelyand-Jones
Frm Director MGill and Emory Cancer Centers
Bill Doyle
CEO Novocure, Frm Head Licensing of at J&J
Dr. Roy Herbst
Chief Medical Oncology - Yale Cancer Center
Christiana Bardon
Partner, MPM Capital
Fred Frank
Noted HC Banker - Vice Chair, Barclays, Smith Barney, Lehman, Burill, EVOLUTION
Dr. Andrew Lo
Director of MIT's Laboratory for Financial Engineering
Fred Nazem
Founder, Nazem Compnies / CEO & Chairman of Oxford Health
Padmanee "Pam" Sharma
Professor, MD Anderson
Keith Flaherty
Director of Clinical Research, Mass General Cancer Center
Reiner Brentjins
Director of Cellular Therapies, Memorial Sloan
Wei Zhang
Director of Cancer Genomics and Precision Oncology, Comprehensive Cancer Center of Wake Forest
Abe Heifets
CEO, Atomwise
Amir Jafri
Frm Head of R&D of Cardinal Health, CEO Immunicom
Tina Yu
Managing Partner Yuanming Capital. CEO Mevion